Research letters

  1. Balfour Lynn IM, Valman HB, Stanway G & Khan M. Use of the polymerase chain reaction to detect rhinovirus in wheezy infants.  Arch Dis Child 1992;67:760.

  2. Balfour-Lynn IM, Madge S, Dinwiddie R. Carrier testing in children for cystic fibrosis. BMJ 1995;310:530.

  3. Balfour-Lynn IM. Importance of using markers of dilution when measuring inflammatory mediators in nasal lavage. J Infect Dis 1996;173:1049.

  4. Balfour-Lynn IM. Quantitative evaluation of nasal mucus proteins. Clin Exp Allergy 1999;29:719.

  5. Balfour-Lynn IM, Dezateux C. Corticosteroids and ibuprofen in cystic fibrosis. Thorax 1999;54:657.

  6. Balfour-Lynn IM, Break dancer’s lungs. Arch Dis Child 2002;86:224. Print paper.

  7. Thursfield RM, Balfour-Lynn IM. Awareness of guidelines on pleural infection. Arch Dis Child 2007;92:652. Print paper.

  8. Regamey N, Hilliard TN, Saglani S, Zhu J, Balfour-Lynn IM, Rosenthal M, Jeffery PK, Alton EW, Bush A, Davies JC. Endobronchial biopsy in childhood. Chest 2008;133:312; author reply 313.

  9. Brown SM, Balfour-Lynn IM. Duration of intravenous antibiotic treatment for respiratory exacerbations in children with cystic fibrosis. Arch Dis Child 2010;95:568. Print paper.

  10. Ahmed B, Balfour-Lynn IM, Alshafi K. Cough swabs should not be used to isolate non-tuberculous mycobacteria in children with cystic fibrosis. Arch Dis Child 2012;97:854-5. Print paper.

  11. Bentley S, Gupta A, Balfour-Lynn IM. Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis. J Cyst Fibros 2012 Oct 23. pii: S1569-1993(12)00181-6. doi: 10.1016/j.jcf.2012.09.007. [Epub ahead of print]. Print paper.

  12. Polychronakis T, Davies G, Balfour-Lynn IM. Susceptibility to Varicella Zoster of children with cystic fibrosis. J Cyst Fibros. 2014;13:353-4. Print paper.

  13. Hayes D Jr, Wilson KC, Balfour-Lynn IM. Need for international standardization of home oxygen therapy in children. Pediatr Pulmonol. 2019 Oct;54:1496. Print paper